During the past decade, Chubu-Rosai Hospital conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 5 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 4 clinical trials were completed. i.e. 30.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Chubu-Rosai Hospital" #1 sponsor was "Boehringer Ingelheim" with 5 trials, followed by "Eli Lilly and Company" with 3 trials sponsored, "Janssen Research & Development, LLC" with 2 trials sponsored, "Pfizer's Upjohn has merged with Mylan to form Viatris Inc." with 2 trials sponsored and "ASKA Pharmaceutical Co., Ltd." with 2 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Chubu-Rosai Hospital" #1 collaborator was "Bristol-Myers Squibb" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator and "Medical Research Council Population Health Research Unit, CTSU, University of Oxford (academic lead)" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Chubu-Rosai Hospital" are "Chronic Kidney Disease" (2 trials), "Rheumatoid Arthritis" (2 trials), "Alzheimer Disease" (1 trials), "Arthritis" (1 trials) and "Arthroplasty, Replacement, Knee" (1 trials). Many other conditions were trialed in "Chubu-Rosai Hospital" in a lesser frequency.

Most popular intervention types in "Chubu-Rosai Hospital" are "Drug" (18 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (12 trials), "BI 685509" (2 trials), "Empagliflozin" (2 trials), "ASA 100 mg" (1 trials) and "Baricitinib" (1 trials). Other intervention names were less common.

The vast majority of trials in "Chubu-Rosai Hospital" are 17 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Chubu-Rosai Hospital". undefined are not yet recruiting, 5 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in Chubu-Rosai Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Chubu-Rosai Hospital, 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".